ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ajinomoto Bio-Pharma and Revance Therapeutics Partner
December 23, 2020Ajinomoto Bio-Pharma Services and Revance Therapeutics Inc. have signed a strategic commercial manufacturing agreement for the supply of DaxibotulinumtoxinA for Injection. -
FDA defers approval of DaxibotulinumtoxinA for Injection in glabellar lines due to Covid-19 related travel restrictions
November 30, 2020Revance Therapeutics announced that the United States (U.S.) Food and Drug Administration (FDA) has deferred a decision on the Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection, an investigational neuromodulator product for the ...
Pharma Sources Insight January 2025
